Komodo Health

A recent industry-wide survey reveals disconnects and unmet needs pertaining to real-world patient data and analytics that can impact business decision making.

A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more. Hear Web Sun, President and Co-founder of Komodo Health, share what's driving these challenges and how you can overcome them.

Discover MapLab, an all-in-one offering for healthcare and Life Sciences companies to generate insights into disease trends, treatment pathways, patient populations, and a host of other complex research questions.

Insight into the complete patient journey not only offers new ways to empower field teams, it is also key to surfacing more HCPs who treat patients with your target condition.

Readily available real-world data and advanced solutions are being used to stitch together the full patient journey, and these longitudinal insights are being used to identify and characterize trial populations and inform clinical trial design and execution strategies.

Webinar Date/Time: Tuesday, Dec 6, 2022, 11am PT | 2pm ET

Thu, Aug 18, 2022 2:00 PM EDT Value for patients, value for all. Learn how today’s health equity initiatives are shaping best-in-class clinical development frameworks of the future.

Now Available On Demand! Building the best! Learn how to leverage real-world evidence and the newest patient insights to ensure you are building the most comprehensive, compliant, and diverse clinical trials.

Tuesday, October 5, 2021 at 2pm EDT | 11am PDT | 7pm BST | 8pm CEST True patient-centricity requires a new approach to data and insights, requiring deep integration into the fabric of the Life Sciences enterprise. Register for this webinar to learn more about the power of real-time, patient-level data throughout every step of the brand lifecycle – from R&D to commercialization and beyond.